Stockreport

Lantern Pharma Reports Third Quarter 2025 Financial Results and Provides Business Updates

Lantern Pharma Inc.  (LTRN) 
PDF Transformational Quarter Marked by Clinical Validation, Regulatory Progress, and Strategic Momentum in Commercial AI Platform LaunchLP-184 Phase 1a clinical trial result [Read more]